Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+0.43%
SPX
+0.27%
IXIC
+0.09%
FTSE
-0.60%
N225
-0.19%
AXJO
-0.11%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Overview

Loading chart...

About

What does VCYT do?
Veracyte, headquartered in South San Francisco, develops diagnostic products for various cancers and employs 815 people. The company went public in 2013 and offers tests like Afirma and Decipher.
Sector
💻 Health Care
IPO
CEO
Employees
Headquarters
California, USA
Website
http://www.veracyte.com

Key Stats

Market Cap
2.15B
Dividend Yield
0.00%
P/E Ratio
64.90
EPS
0.32
Revenue
445.76M
Avg. Volume
1.13M
Stocks
Health Care
vcyt
Veracyte
VCYT
+0.42 (+1.55%)
27.5
USD
At close at Jul 10, 20:38 UTC
Summary
News
Signals
Benchmarks
Financials

Recently from Cashu

publisher logo
Cashu

Veracyte: Leading Innovation in Genomic Diagnostics for Enhanced Patient Care

18 days ago
publisher logo
Cashu

Veracyte: Transforming Cancer Diagnostics Through Innovative Genomic Technologies

20 days ago
publisher logo
Cashu

Veracyte's Commitment to Diagnostic Innovation and Personalized Medicine Opportunities

29 days ago